FOXM1 and ovarian carcinoma: Consistent with previous reports [14], [25], FOXM1C could increase the cell proliferation capacity in A2780cp (P<0.005) and OVCA433 (P = 0.006) ovarian cancer cells, while FOXM1B just showed slight increased effect (Fig. 2A).